Cryptococcal infections in children: retrospective study and review from Australia

Alice Grimshaw1, Pamela Palasanthiran2,3, Julie Huynh4,5

  • 1University of New South Wales, Kensington, New South Wales, 2052, Australia.

Future Microbiology
|January 30, 2020
PubMed

Insights

Cryptococcosis in Australian children is rare but serious. Most pediatric cases involve central nervous system infections, with significant mortality and long-term health issues for survivors.

Area of Science:

  • Medical Mycology
  • Pediatric Infectious Diseases
  • Epidemiology

Background:

  • Cryptococcosis presents a global health challenge with considerable morbidity and mortality.
  • Limited data exist regarding the epidemiology and clinical outcomes of cryptococcosis in pediatric populations.

Purpose of the Study:

  • To investigate the incidence, clinical characteristics, and outcomes of cryptococcosis in Australian children.
  • To review existing literature and conduct a network audit of pediatric cases.

Main Methods:

  • A retrospective literature review identified Australian pediatric cryptococcosis cases.
  • A 10-year audit of cases from a major pediatric network was performed.
  • Data analysis focused on patient demographics, clinical presentation, causative species, treatment, and outcomes.

Main Results:

  • Twenty-two pediatric cases were identified through literature review, with a median age of 13.5 years; 82% had meningitis or CNS infection, and 61% of reported outcomes were fatal.
  • In a 2008-2017 audit, five of six pediatric cases involved Cryptococcus gattii and survived; one child with acute lymphoblastic leukemia and Cryptococcus neoformans infection died.
  • Among survivors, 67% experienced persistent neurological or respiratory sequelae.

Conclusions:

  • Cryptococcosis is an infrequent but severe infection in Australian children.
  • The condition is associated with significant morbidity, including neurological and respiratory complications.
  • Prompt diagnosis and management are crucial for improving outcomes in pediatric cryptococcosis.